Clinical trials
Phase 1/2 COVID-19 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 30 |
| 2021 | 16 |
| 2022 | 7 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Terminated | 14 |
| Withdrawn | 6 |
| Recruiting | 4 |
| Unknown status | 4 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stanford University | 3 |
| BioNTech SE | 2 |
| Regeneron Pharmaceuticals | 2 |
| Sanofi Pasteur, a Sanofi Company | 2 |
| ZEO ScientifiX, Inc. | 2 |
| AVEM HealthCare | 1 |
| All Natural Medicine Clinic, LLC | 1 |
| Amanda Stapleton | 1 |
| Apellis Pharmaceuticals, Inc. | 1 |
| Arcturus Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 60 |
| Coronavirus Infections | 13 |
| Respiratory Distress Syndrome | 12 |
| Pneumonia | 5 |
| Virus Diseases | 5 |
| Acute Lung Injury | 4 |
| Severe Acute Respiratory Syndrome | 4 |
| Influenza, Human | 3 |
| Lung Diseases | 3 |
| Anosmia | 2 |
Trials
Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.